These data indicate that fibroblasts from ILD patients with mild disease undergoing diagnostic biopsy have higher TGF-β1 and proinflammatory pathway signaling than either donor tissue or end-stage explant ILD tissue. This evidence concerns the gene TGFB1 and interstitial lung disease.